is noom semaglutide safe launches full-page ad in Wall Street Journal advocating for policy changes regarding compounded GLP-1s Do NOT use Noom :

Clinical trials show tirzepatide produces 22.5% average weight loss compared to semaglutides 14.9%, likely because activating both incretin pathways provides more comprehensive metabolic regulation than activating one pathway alone

Ozempic consistently demonstrates superior blood sugar lowering in comparison studies

BMI, body mass index: CVD, cardiovascular disease

Guven DC, Erul E, Kaygusuz Y, Akagunduz B, Kilickap S, De Luca R, et al

Growth hormone and IGF-1 are involved in muscle protein synthesis, fat oxidation, and tissue repair, so it is reasonable that restoring more youthful GH signaling could influence those areas